IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,240,871 | -14.9% | 2,470,521 | +31.6% | 0.40% | -33.2% |
| Q2 2023 | $13,212,771 | +4.9% | 1,876,814 | -9.0% | 0.60% | -15.6% |
| Q1 2023 | $12,597,684 | -4.4% | 2,061,814 | 0.0% | 0.71% | -21.6% |
| Q4 2022 | $13,174,991 | +46.9% | 2,061,814 | +120.3% | 0.91% | +4.0% |
| Q3 2022 | $8,967,000 | -50.0% | 936,000 | -42.4% | 0.87% | -53.5% |
| Q2 2022 | $17,940,000 | +52.8% | 1,625,000 | +130.5% | 1.88% | +24.7% |
| Q1 2022 | $11,738,000 | +17.1% | 705,000 | +34.3% | 1.51% | +13.6% |
| Q4 2021 | $10,022,000 | – | 525,000 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |